Oragenics Inc (OGEN)

0.392 +0.01 (+3.70%) USD  |  NYAM  |  Dec 26, 16:00
0.3675 -0.02 (-6.25%) After-Hours: 07:56
More

Oragenics Research and Development Expense (Quarterly): 0.879M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for OGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Microbot Medical Inc 2.06M
Alaunos Therapeutics Inc 0.143M
SELLAS Life Sciences Group Inc 4.362M
Galectin Therapeutics Inc 7.595M
Anavex Life Sciences Corp 11.56M